Strains of Friend leukemia virus (FLV) that are associated with polycythemia contain the defective spleen focus-forming virus (SFFV). To determine whether the transforming ability of FLV was affected by the presence of this second agent, DBA/2J mouse bone marrow cells were infected in vitro. Criteria for transformation were the establishment of permanent lines, growth on semisolid agarose, and the production of tumors at the site of inoculation in syngeneic hosts. (FLV) causes erythroleukemia in susceptible strains of adult mice after a short latent period (1, 2). This model resembles Di Guglielmo disease in humans in that it is characterized by a rapid proliferation of primitive hematopoietic cells and is associated with an erythropoietic response. Although FLV has been shown to influence the activity of other types of blood cells (3-6), the primary target for FLV in vivo is an erythroid precursor (7-9). While the prototype virus (FLV-A) induces erythroleukemia accompanied by anemia (1, 2), some strains, designated FLV-P, induce the same type of erythroleukemia but associated with polycythemia (10). Antiserum to either strain neutralizes the infectivity of the other, although FLV-P is thought to contain a complex of viruses, among which is the defective spleen focus-forming virus (SFFV) (11). The polycythemia is attributed to its activity. Removal of SFFV from FLV-P preparations eliminates the polycythemia-inducing factor without altering the leukemogenic activity (12, 13). Thus, the role of SFFV in the pathogenesis of FLV-induced erythroleukemia in vio is not clear. SFFV is expressed only in the presence of a "helper," which may be supplied by a variety of viruses and nonviral agents (14-18).We have compared the ability of the two FLV strains to transform hematopoietic cells in vitro in an effort to clarify the role that SFFV may play in the pathogenesis of the leukemia in vivo. The preceding report (19) described the transformation of mouse fetal liver cells infected in vitro with FLV-A, which lacks SFFV activity. The results of parallel studies on the transformation of mouse bone marrow cells infected with FLV-P in vitro is the subject of this communication.The criteria for transformation were altered morphology, establishment of cells in continuous culture, growth on soft agar, and tumorigenicity in syngeneic hosts. Two permanent lines of malignant hematopoietic cells originated from cultures of DBA/2 mouse bone marrow cells infected in vitro with FLV-P. Each grows in suspension, can be cloned on soft agar, and produces tumors in syngeneic mice. The erythroid nature of the transformed cells was verified by stimulation of differentiation after treatment with dimethyl sulfoxide (Me2SO) (9) and hexamethylene bisacetamide (HMBA) (20).
MATERIALS AND METHODSVirus. Stock FLV-P virus was prepared from filtrates of leukemic spleens of polycythemic DBA/2J male mice (Jackson Laboratory), as described (1), and stored at -180°C. The LD5o (mean lethal dose) of the virus titered for leukemogenicity in 6-to 8-wee...